January 8th, 2025 – Numantec, a European leader in the medical devices market, has acquired Health Line International Corp., a US-based company specializing in the production and distribution of vascular access catheters, infusion therapy products, and infection control devices.
Headquartered in Salt Lake City, Utah, Health Line is among the few companies worldwide to offer a comprehensive and certified (MDR-compliant and FDA-approved) portfolio of critical care vascular access products. The company operates a well-invested facility with significant capacity to support future growth.
This partnership enables the Group to unlock substantial synergies and accelerate its growth trajectory by combining Health Line’s strong foothold in the US market with Numantec’s established presence in Europe. Additionally, the robust complementarity of the product portfolios positions the Group as a global leader in infusion medical devices.
As part of the transaction, the Faulkner Family will reinvest a portion of the proceeds into the Group, demonstrating their commitment and alignment of interests. Joel Faulkner, CEO of Health Line since its inception, will retire. Elliot Faulkner will be appointed CEO of Health Line, with the responsibility to grow the Critical Care business globally, while Aaron Faulkner will continue to lead as VP, Regulatory Affairs and Quality Assurance. The core management team of Health Line will also remain in place. White Bridge Investments, Numantec’s main shareholder, will continue to be the controlling shareholder of the Group.
Elliot Faulkner, CEO of Health Line, said: “We believe that Numantec is the ideal partner to support us in our next phase of growth. This partnership, uniting two entities with distinct histories and shared values, provides a strong foundation to invest in the development of our firm. Our active roles as shareholders and managers underscore our commitment and confidence in the Group’s potential to become a global leader in vascular access and infusion systems.”
Gabriele Giovanelli, CEO of Numantec, added: “Health Line is a well-recognized manufacturer of critical care vascular accesses, which allowed the company to experience a significant growth trajectory both in the US and internationally. The partnership between Health Line and Numantec will enable the Group to consolidate its leadership. This represents another step in the platform strategy that the Group is pursuing following White Bridge Investments acquisition of Delta Med in October 2021.”
In the transaction Numantec was assisted by White&Case LLP as legal advisor, with partners Alessandro Seganfreddo and Michael Immordino, and associates Mariasole Maschio and Vincenzo Ferrini. Plante Moran was responsible for the financial and tax due diligence as well as general tax consulting with a team led by Scott Sneckenberger with Pero Ogrizovich and Beth Babich on the financial side and by Rob Shefferly, Don Stanovcak with Jill Davenport on the tax side. WTW acted as insurance advisor with Gian Paolo Polto and Gabriele Galimberti. Intexo was responsible for the regulatory due diligence with Pietro Caiazza. Proj.Eco Engineering was in charge of the HSE due diligence conducted by Federico Bugliaro Goggia and the local partner Antea Group with John Ruksenas, Allan Dudding, Kelley Baker and Ed Petrie assisting.
Health Line was supported by Kirton McConkie with the legal advisors Timothy Burton Anderson, Trevor Crowley, Adam Channer, Nathan Jackson, Justin Pitcher, Ken Birrell and Ryan Frazier.
The transaction was financed by a bank pool led by Banco BPM (agent bank) with Federico Born and Daniele Silva.